Colonoscopy‐controlled intra‐individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac‐based faecal occult blood test

Aliment Pharmacol Ther 31, 432–439 Summary Background  Guaiac‐based faecal occult blood tests (g‐FOBTs) are most commonly used in colorectal cancer (CRC) screening programmes. Faecal immunochemical tests (FITs) are thought to be superior. Aim  To compare performance of a g‐FOBT and a quantitative FI...

Full description

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 2010-02, Vol.31 (3), p.432-439
Main Authors: OORT, F. A., TERHAAR SIVE DROSTE, J. S., VAN DER HULST, R. W. M., VAN HEUKELEM, H. A., LOFFELD, R. J. L. F., WESDORP, I. C. E., VAN WANROOIJ, R. L. J., DE BAAIJ, L., MUTSAERS, E. R., VAN DER REIJT, S., COUPE, V. M. H., BERKHOF, J., BOUMAN, A. A., MEIJER, G. A., MULDER, C. J. J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aliment Pharmacol Ther 31, 432–439 Summary Background  Guaiac‐based faecal occult blood tests (g‐FOBTs) are most commonly used in colorectal cancer (CRC) screening programmes. Faecal immunochemical tests (FITs) are thought to be superior. Aim  To compare performance of a g‐FOBT and a quantitative FIT for detection of CRCs and advanced adenomas in a colonoscopy‐controlled population. Methods  We assessed sensitivity and specificity of both FIT (OC‐sensor) and g‐FOBT (Hemoccult‐II) prior to patients’ scheduled colonoscopies. Results  Of the 62 invasive cancers detected in 1821 individuals, g‐FOBT was positive in 46 and FIT in 54 (74.2% vs. 87.1%, P = 0.02). Among 194 patients with advanced adenomas, g‐FOBT was positive in 35 and FIT in 69 (18.0% vs. 35.6%, P 
ISSN:0269-2813
1365-2036
DOI:10.1111/j.1365-2036.2009.04184.x